Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
927 participants
INTERVENTIONAL
2020-04-16
2023-07-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women's Depression
NCT04368208
Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological Impact
NCT04366817
Study of the Identification of Childbirth Trauma in the Birth Room by Midwives.
NCT06204757
Psychological Impact of COVID19 Among Women Undergoing Infertility Treatment
NCT04496869
Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic
NCT04377412
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The secondary objectives are:
1. To compare, at two months post-partum, the maternal sense of control during childbirth between the three groups.
2. To compare, at two months of post-partum, scoring of self-questionnaire Edinburg Postnatale Depression Scale (EPDS) for the post-natal depression between the three groups.
3. To compare at two months of post-partum, scoring of self-questionnaire Impact of Event Scale - Revised (IES-R) for posttraumatic stress disorder, between the three groups.
4. To compare, at two months of post-partum, the breastfeeding between the three groups.
5. To compare, at two months of post-partum, the quality of life (SF-12) between the three groups.
6. To compare the evolution of quality of life at two months of post-partum between the three groups.
7. To compare the rate of post-natal depression between the three groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Confinement group
Delivery during covid-19 confinement period
Self-administered questionnaires
Self-administered questionnaires once during the post-natal hospitalization and a second time 7 to 9 weeks after the delivery (at home)
Control group
Delivery after the withdrawal of all sanitary measures (mask, social distancing, limited visits during post-partum immediate)
Self-administered questionnaires
Self-administered questionnaires once during the post-natal hospitalization and a second time 7 to 9 weeks after the delivery (at home)
Epidemic group
Delivery after confinement period and before the withdrawal of sanitary measures implemented (mask, social distancing, limited visits during post-partum immediate)
Self-administered questionnaires
Self-administered questionnaires once during the post-natal hospitalization and a second time 7 to 9 weeks after the delivery (at home)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Self-administered questionnaires
Self-administered questionnaires once during the post-natal hospitalization and a second time 7 to 9 weeks after the delivery (at home)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Woman having just given birth from 37 weeks of gestation (singleton pregnancy)
* Woman affiliated to a social security
* Woman with a level of understanding of written French sufficient to answer the questionnaires.
* Woman having received complete information on the organization of the research and having given her informed consent in written form.
For "epidemic" group: Delivery after confinement period and before the withdrawal of sanitary measures implemented (mask, social distancing, limited visits during post-partum immediate)
For "control" group: Start of pregnancy after confinement and delivery after the withdrawal of all sanitary measures (mask, social distancing, limited visits during post-partum immediate)
Exclusion Criteria
* Woman with psychiatric disorders such as depressive syndrome
* Woman considered positive for covid-19 and treated as such at the time of delivery (regardless of test result)
* Newborn with congenital abnormalities
* Stillbirth
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
BERTHOLDT Charline
Principal Investigator (obstetrician-gynecologist)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charline BERTHOLDT
Role: STUDY_CHAIR
Central Hospital, Nancy, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Régional Universitaire de Nancy
Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bertholdt C, Epstein J, Banasiak C, Ligier F, Dahlhoff S, Olieric MF, Mottet N, Beaumont M, Morel O. Birth experience during COVID-19 confinement (CONFINE): protocol for a multicentre prospective study. BMJ Open. 2020 Dec 10;10(12):e043057. doi: 10.1136/bmjopen-2020-043057.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A00881-38
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.